What were the Q-Line Biotech Limited IPO listing gains?

Q-Line Biotech Limited listed on 29 May 2026 at ₹452, closing its first day at ₹475 — a listing gain of +38.4% versus the ₹343 issue price.

What was the price band and lot size of the Q-Line Biotech Limited IPO?

The price band was ₹326–₹343 per share.

Who were the registrar and lead manager for the Q-Line Biotech Limited IPO?

Purva Sharegistry (India) Private Limited was the registrar, and HEM Securities was the book-running lead manager.

Q-Line Biotech Limited IPO

Q-Line Biotech Limited was a SME IPO in the Medical Equipment & Supplies sector, offered at ₹326–₹343 per share to raise ₹214 crore. It listed on 29 May 2026 at ₹452 and closed its first day at ₹475, a listing gain of +38.4% versus the ₹343 issue price. It now trades around ₹513 (+49.5% versus the issue price).

Frequently asked questions

What were the Q-Line Biotech Limited IPO listing gains?: Q-Line Biotech Limited listed on 29 May 2026 at ₹452, closing its first day at ₹475 — a listing gain of +38.4% versus the ₹343 issue price.
What was the price band and lot size of the Q-Line Biotech Limited IPO?: The price band was ₹326–₹343 per share.
Who were the registrar and lead manager for the Q-Line Biotech Limited IPO?: Purva Sharegistry (India) Private Limited was the registrar, and HEM Securities was the book-running lead manager.